“…Outcome variability in focal neuromodulation studies might reflect a host of factors, including suboptimal stimulation targets, and functional neuroimaging (e.g., resting-state fMRI) may yet play a role in assessing target selection and engagement in individual patients (Cash et al, 2021;Cole et al, 2020Cole et al, , 2022Fitzgerald, 2021;Fox et al, 2012;Nord et al, 2019;Price et al, 2021;Siddiqi et al, 2021a;Weigand et al, 2018;Weissman and Daskalakis, 2022). Furthermore, neuroimaging-based techniques such as lesion network mapping show promise in identifying new anatomical targets that are causally implicated in therapeutic change (Joutsa et al, 2022;Siddiqi et al, 2020Siddiqi et al, , 2021bSiddiqi et al, , 2022. Nevertheless, it remains the case that mappings between neuroanatomical loci and psychiatric diagnoses or symptoms have remained elusive.…”